Skip to main content
Market intelligence
RVMDHealthcare

Revolution Medicines Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 16, 2026Anthony ManciniSee RemarksSale1,774$199.24$353,449
Sep 16, 2026Jeff CisliniSVP & General CounselSale3,366$199.24$670,631
Sep 16, 2026Alan B. SandlerChief Development OfficerSale341$199.24$67,941